MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Trading in Medincell (Paris:MEDCL) shares on Euronext Paris was suspended as of the market opening at 9:00 a.m. (CEST), at the Company’s request, pending the publication of a press release. About Medincell Medincell is a clinical- and commercial-stage innovation-driven biopharmaceutical company developing and licensing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are designed to ensure adher